Theme: Exploring the Research Challenges & Advancements in Pharmaceutical Sciences

Pharma-2015

Renowned Speakers

Pharma-2015

OMICS International Conferences invites all the participants across the globe to attend Global Pharma Summit during August 10-12, 2015 in Philadelphia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Pharma-2015 is a specially designed cluster conference, which provides a deep, thorough knowledge of pharmaceutical education and current novel trends in pharmaceutical sciences with the theme of “Scrupulous knowledge of Pharmaceutical Sciences” which covers a wide range of critically important sessions.OMICS International is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. USA holds the best renowned pharma association, as well as the reputed universities in the field holds the significance of the Pharma 2015.

OMICS International Organizes 300+ Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. Pharmaceutical conference series oraganised round the globe reflects the updates in pharmacy to all its professionals.

According to “Pharmerging”17 market share forecast 2014, United States hold 33% of the global market share which is followed by Europe with 16%, Japan with 10% and Rest of the world. United states include 4 pharmaceutical companies in top 10 throughout the world. Johnson & Johnson and Pfizer are the top two pharma companies in the world which are located in USA. 

Track 1: Preformulation Studies:

Preformulation studies track of the Global Pharma Summit involves the characterization of a drug's physical, chemical, and mechanical properties in order to choose what other ingredients should be used in the preparation. In dealing with protein pre-formulation, the important aspect is to understand the solution behavior of a given protein under a variety of stress conditions such as freeze/thaw, temperature, shear stress among others to identify mechanisms of degradation and therefore its mitigation.  Global pharma companies are mainly focussing on the these studies to prevent scale up problems.The analytical aspects of the drug and excipients used in the formulation should be highlighted with the type of interactions that might be possible for which analytical methods are useful. Polymorphism is a specific characteristic that is to be considered prior to formulation, in order to select the type of tooling and other parameters this character of the drug and excipients play a crucial role. The possible problems usually associated when the scaling up of the formulation is being done.

Track 2: Biopharmaceutical Sciences:

A biopharmaceutical, also known as a biologic medical product or biologic, is extracted from, or semisynthesized from biological sources. The Biopharmaceutics includes the drugs classification according to their rate and extent of absorption and permeability to different classes BCS classification of drugs. Based on the type of class the excipient class should be selected. The kind of disposition the formulation is going to follow should be estimated by different models. Also the IVIVC should be done so as to correlate the values obtained in vitro to in vivoPharmaceutical conferences USA accounts with the focus on the productivity, quality and sales of several drugs. The Bio availability and Bio Equivalence of the formulations are to be studied at each level of study. The advantages and possible problems associated to the Multiple dosing and the side effects that may result on slight over use or under use should also be studied and specified to ensure safety profiling to the patient.

Track 3: Novel Drug Delivery Systems:

Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effect. It may involve scientific site-targeting within the body, or it might involve facilitating systemic Pharmacokinetics. Drug delivery technologies modify drug release profile, absorption, distribution and elimination for the benefit of improving product efficacy and safety, as well as patient convenience and compliance. This conference of Global Pharma Congress is going to mainly show the challenges in success of the novel drug delivery systems.These drug delivery mechanisms may be either Immediate or controlled. These controlled delivery is achievable with the usage of some Osmotic devices/transdermal systems. These devices sometimes may be invivo systems like the Red blood cells also which are called as Resealed Erythrocytes or some of the lipids as carriers which constitute the Liposomes, Niosomes, Ethosomes etc., even the proteins and nucleotides may be used as potential carriers. The route of drug delivery also concern as the Oral DDS< Parenteral DDS in relation to the absorption rate and extent the targeted devices also play an important role in gaining more drug to site of action. 

Track 4: Industrial Pharmacy:

Pharmaceutical firms are engaged in the discovery, manufacturing, and marketing of legal drugs, biologics (viruses, toxins, serums, and analogous products), vaccines, and medical devices such as pacemakers and prosthetics. Products are made for both humans and animals. Drug discovery and development are important for any pharmaceutical industry to build up its economy. New molecules with new techniques of preparation at economical grade without compromising with quality is a major task to R&D. Various Clinical trials are to be done in different phases on animals, healthy and patient volunteers so as to estimate the suitability of the product formulation before it gets release to the market. Even after the formulation is released the Post marketing surveillance should be done to analyze the long term effects. 

Track 5: Drugs and Medical Devices:

Regulatory affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, banking, telecom etc. Several regulations are made by different organizations, so as to check the quality and effectiveness of the product. In order to formulate a drug the Pharmaceutical industries should meet up the several requirements of the USFDA and GMP norms and it should also file up different applications like NDA, INDA, SNDA at different stages of processing. The patient compliance is the utmost criteria made by the Regulatory bodies, also the cost of the formulation is also to be strictly maintained all through the seasons. The marketing strategies to the drugs and health care sectors should be scrutinized at various levels as they might be misleading if gone through the Mass media. Drug Safetyand drug rediscovery should be made concomitantly to meet the safety requirements.

Track 6: Pharmacological Sciences:

It is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. Pharmacology, a biomedical science, deals with the research, discovery, and characterization of chemicals which show biological effects and the elucidation of cellular and organismal function in relation to these chemicals. With special focus on each sector the pharmacological sciences may be related to nerves, heart, hormones, kidneys, immune system, clinical aspects and the type of behavior. The names were given relatively as neuro-pharmacology, cardiovascular pharmacology, endocrinology, uro-genital pharmacology, immunology, clinical pharmacology & behavioral pharmacology.

Track 7: Pharmacognosy & Phytochemistry:

Pharmacognosy is the study of medicines derived from natural sources. Pharmacognosy as "the study of the physical, chemical, biochemical  and biological properties of drugs, drug substances or potential drugs or drug substances of natural origin as well as the search of new drugs from natural sources. Computational chemistry and biochemistry are the part ofphytochemistry.Global market of the drugs produced from the naturally have a great acceptance from the patients, which will be elaborately included. Pharmacognosy and also phytochemistry involves in dealing with the strategies in identification & development of new drugs. Phytochemistry is the type of chemistry which is derived from plants or the metabolic compounds derived from plants. Pharmacognosy also deals with protein structure prediction and molecular simulation.

Track 8: Current Trends in Pharma- Nanotechnology:

Nanotechnology as defined by size is naturally very broad, including fields of science as diverse as surface science, microfabrication. The associated research and applications are equally diverse, ranging from extensions of conventional device physics to completely new approaches based upon molecular self assembly, from developing new materials with dimensions on the nanoscale to direct control of matter on atomic scale. Bio computing is the construction and use of computers that functions like living things or having biological components such as DNA. Bio computing is also used in bioinformatics to assist the biological research. Bio computing uses Bio computers which uses biologically derived molecules such as Proteins and DNA. These are used for computational calculations including data storage, data retrieve data processing etc. therefore Biocomputing is a part of nanotechnology. Nanotechnology also includes bio nanotechnology.  It is a branch of nanotechnology which uses biological materials or in biotechnology.

Track 9: Pharmacogenetics:

It is the study of inherited genetic differences in drug metabolic pathways which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects. The term pharmacogenetics is often used interchangeably with the term pharmacogenomics which also investigates the role of acquired and inherited genetic differences in relation to drug response and drug behavior through a systematic examination of genes, gene products, and inter- and intra-individual variation in gene expression and function. sequence search and analysis, functional genomics, bio engineering issues and many other topics come under pharmacogenetics. Bioengineering or also called as biological engineering is the method to solve the problems related to life sciences. Tissue engineering is the use of combination of cells, engineering to improve or replace biological methods.

Track 10: Pharmaceutical Ethics & IPR:

Intellectual property rights (IPR) have been defined as ideas, inventions, and creative expressions based on which there is a public willingness to bestow the status of property. IPR provide certain exclusive rights to the inventors or creators of that property, in order to enable them to reap commercial benefits from their creative efforts or reputation. There are several types of intellectual property protection like patent, copyright, trademark, etc. Patent is recognition for an invention, which satisfies the criteria of global novelty, non-obviousness, and industrial application. IPR is prerequisite for better identification, planning, commercialization, rendering, and thereby protection of invention or creativity. Pharmaceutical industry currently has an evolving IPR strategy requiring a better focus and approach in the coming era. Ethics in pharmaceutical sector deals with various areas such as human trial ethics, experimental animal ethics. It also relates with patent and dispute case studies and identification studies between adulterated and misbranded drugs.

Track 11: Bioinformatics in Healthcare System:  

Exponentially growing biological and bioinformatics data sets present a challenge and an opportunity for researchers to contribute to the understanding of the genetic basis of phenotypes. Due to breakthroughs in microarray technology, it is possible to simultaneously monitor the expressions of thousands of genes, and it is imperative that researchers have access to the clinical data to understand the genetics and proteomics of the diseased tissue. In this paper, we explore the computational and ethical challenges that emanate from the intersection of bioinformatics and healthcare informatics research Finally, we posit that the synergy obtained from the collaborative efforts between the genomics, clinical, and healthcare disciplines has potential to enhance and promote faster and more advanced breakthroughs in healthcare. Bioinformatics also known as healthcare informatics includes various studies or the sub topics as biomedicine, telemedicine, genomics and proteomics, case report management, biomedical signal analysis. Biomedicine is a branch of medical science that can be applicable in natural science and also in healthcare informatics. Telemedicine is the use of telecommunication and information technologies in order to provide clinical health care at a distance. It is also used in healthcare informatics or bioinformatics in healthcare system.  

 

 

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 10-12, 2015
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View